TechSeeker Profile

Genentech Inc
Profile last edited on: 1/24/2017

biotechnology company, engages in the research, discovery, development, manufacture, and commercialization of medicines using human genetic information to treat patients with serious or life-threatening medical conditions in the United States.
TS Type
Major Corp
Year Founded
Last Involved Year

Key People / Management

  Peter Loescher -- President

  Laura E Berner --

  Patrick Bigot --

  Matthew R Cohen --

  Kathleen V Donovan --

  Greg Jensen -- Life Science Business Dev

  Todd J Johnson --

  Jonathan Lewis -- Senior Manager, Business

  Gary Loeb -- Senior Patent Counsel

  Johanna L Lucas --

  Joseph S McCracken --

  Joseph S McCracken -- Vice President, Business

  T Shane Shih -- Market Planning Manager

  Dana G Tolari --

Location Information

1 DNA Way
South San Francisco, CA 94080-4990
   (650) 225-1000

Public Profile

Genentech Inc., a portmanteau of Genetic Engineering Technology, Inc., is a biotechnology corporation, which was founded in 1976 by venture capitalist Robert A. Swanson and biochemist Dr. Herbert Boyer.[1][2] It is considered to have founded the biotechnology industry.[1][2] One of its founders, Boyer, is considered to be a pioneer in the field of recombinant DNA technology. In 1973, Boyer and his colleague Stanley Norman Cohen demonstrated that restriction enzymes could be used as "scissors" to cut DNA fragments of interest from one source, to be ligated into a similarly cut plasmid vector. While Cohen returned to the laboratory in academia,[1] Swanson contacted Boyer[3] to found the company.[1] Boyer worked with Arthur Riggs and Keiichi Itakura from the Beckman Research Institute, and the group became the first to successfully express a human gene in bacteria when they produced the hormone somatostatin in 1977. David Goeddel and Dennis Kleid were then added to the group, and contributed to its success with synthetic human insulin in 1978. As of March 2008, Genentech employed more than 11,000 people and Arthur D. Levinson was the chairman and CEO.[4] The Swiss pharmaceutical conglomerate Hoffmann-La Roche now completely owns Genentech after completing its purchase on 26 March 2009 for approximately $46.8 billion

Extent of SBIR involvement

User Avatar

Synopsis: Techseeker Business Condition

Privately Held
Stock Info
Received SBIR $$

Techseeker firm in the news

There are no news available.